![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Momentus Inc | NASDAQ:MNTS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.071 | 13.05% | 0.615 | 0.55 | 0.865 | 0.661799 | 0.544 | 0.544 | 360,208 | 05:00:04 |
Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company that offers satellite buses, transportation, and other in-space infrastructure services, today announced its financial results for the third quarter of 2023.
"In the third quarter, we saw significant traction in the commercial market that continues into the fourth quarter. We recently announced six contracts to provide hosted payload services and orbital transportation missions," said Momentus Chief Executive Officer John Rood. "We have executed four missions and deployed 18 customer satellites into orbit during our Company’s short history. Our technology is performing, we are earning the trust of new customers, and we have repeat customers, which reflects the cost-effective and reliable services we provide."
"We're focused on advancing our technology on the Vigoride Orbital Service Vehicle and our M-1000 bus as we continue to lean into the commercial and defense markets. We're confident in our capabilities, technology, and team, and we continue to push forward as an in-space infrastructure leader and provider of satellite buses."
Recent Business Highlights:
Conference Call Information
Momentus will host a conference call to discuss the results today, November 14, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). To access the conference call, participants should dial +1 (800) 715-9871 and enter the conference ID number 7376493. International participants should dial +1 (646) 307-1963.
The live audio webcast along with supplemental information will be accessible on the Company’s Investor Relations website at https://investors.momentus.space. A recording of the webcast will also be available following the conference call.
About Momentus Inc.
Momentus is a U.S. commercial space company that offers commercial satellite buses and in-space infrastructure services, including in-space transportation, hosted payloads, and in-orbit services.
Forward-Looking Statements
This press release contains certain statements which may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the evaluation of strategic alternatives, Momentus’ or its management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, and are not guarantees of future performance. The words “may,” “will,” “anticipate,” “believe,” “expect,” “continue,” “could,” “estimate,” “future,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “aim,” “strive,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions.
Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Momentus’ control. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: the ability of the Company to generate revenue and raise capital in order to continue as a going concern; the ability of the Company to obtain licenses and government approvals for its missions, which are essential to its operations; the ability of the Company to effectively market and sell satellite transport services and planned in-orbit services; the ability of the Company to protect its intellectual property and trade secrets; the development of markets for satellite transport and in-orbit services; the ability of the Company to develop, test and validate its technology, including its water plasma propulsion technology; delays or impediments that the Company may face in the development, manufacture and deployment of next generation satellite transport systems; the ability of the Company to convert backlog or inbound inquiries into revenue; changes in applicable laws or regulations and extensive and evolving government regulations that impact operations and business, including export control license requirements; the ability to attract or maintain a qualified workforce with the required security clearances and requisite skills; product service or product or launch failures or delays that could lead customers to use competitors’ services; investigations, claims, disputes, enforcement actions, litigation and/or other regulatory or legal proceedings; the Company’s ability to comply with the terms of its National Security Agreement and any related compliance measures instituted by the director who was approved by the CFIUS Monitoring Agencies; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and/or other risks and uncertainties. These are only some of the factors that may affect the forward-looking statements contained in this press release. For a discussion identifying additional important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, see the company’s filings with the U.S. Securities and Exchange Commission including, but not limited to, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The Company’s filings may be accessed through the Investor Relations page of its website, investors.momentus.space, or through the website maintained by the SEC at www.sec.gov. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
Third Quarter 2023 Financial Results
MOMENTUS INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(in thousands, except share data)
Three Months Ended September 30,
Nine Months Ended September 30,
2023
2022
2023
2022
Service revenue
$
339
$
129
$
2,066
$
179
Cost of revenue
119
14
507
26
Gross profit
220
115
1,559
153
Operating expenses:
Research and development expenses
5,992
10,571
26,315
31,438
Selling, general and administrative expenses
9,294
11,184
29,571
38,898
Total operating expenses
15,286
21,755
55,886
70,336
Loss from operations
(15,066
)
(21,640
)
(54,327
)
(70,183
)
Other income (expense), net:
Change in fair value of warrant liability
221
1,579
559
3,382
Realized loss on disposal of assets
—
(45
)
(17
)
(114
)
Interest income
216
28
1,128
33
Interest expense
(530
)
(1,261
)
(2,182
)
(4,166
)
Other income (expense)
—
41
20
44
Total other income (expense), net
(93
)
342
(492
)
(821
)
Net loss
$
(15,159
)
$
(21,298
)
$
(54,819
)
$
(71,004
)
Net loss per share, basic and diluted
$
(7.20
)
$
(12.98
)
$
(28.45
)
$
(43.77
)
Weighted average shares outstanding, basic and diluted
2,106,707
1,641,308
1,927,049
1,622,316
MOMENTUS INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
September 30, 2023
December 31, 2022
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents
9,750
61,094
Restricted cash, current
394
1,007
Accounts receivable
44
—
Insurance receivable
500
4,000
Prepaids and other current assets
10,469
10,173
Total current assets
21,157
76,274
Property, machinery and equipment, net
3,353
4,016
Intangible assets, net
329
337
Operating right-of-use asset
5,629
6,441
Deferred offering costs
583
331
Restricted cash, non-current
370
312
Other non-current assets
2,068
4,712
Total assets
$
33,489
$
92,423
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
2,517
$
2,239
Accrued liabilities
7,422
8,026
Loan payable, current
5,740
11,627
Contract liabilities, current
1,162
1,654
Operating lease liability, current
1,239
1,153
Stock repurchase liability
—
10,000
Litigation settlement contingency
5,000
8,500
Other current liabilities
22
27
Total current liabilities
23,102
43,226
Contract liabilities, non-current
420
1,026
Loan Payable, non-current
—
2,404
Warrant liability
5
564
Operating lease liability, non-current
5,187
6,131
Other non-current liabilities
483
465
Total non-current liabilities
6,095
10,590
Total liabilities
29,197
53,816
Commitments and Contingencies (Note 12)
Stockholders’ equity:
Common stock, $0.00001 par value; 250,000,000 shares authorized and 2,700,909 issued and outstanding as of September 30, 2023; 250,000,000 shares authorized and 1,688,824 issued and outstanding as of December 31, 2022
—
—
Additional paid-in capital
363,238
342,734
Accumulated deficit
(358,946
)
(304,127
)
Total stockholders’ equity
4,292
38,607
Total liabilities and stockholders’ equity
$
33,489
$
92,423
MOMENTUS INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(in thousands)
Nine Months Ended September 30,
2023
2022
Cash flows from operating activities:
Net loss
$
(54,819
)
$
(71,004
)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
667
831
Amortization of debt discount and issuance costs
1,182
2,114
Amortization of right-of-use asset
812
889
Change in fair value of warrant liability
(559
)
(3,382
)
Loss on disposal of property, machinery, equipment and intangible assets
17
121
Stock-based compensation expense
6,453
8,564
Non-cash consulting expense
112
—
Changes in operating assets and liabilities:
Accounts receivable
(44
)
—
Prepaids and other current assets
(297
)
(1,571
)
Other non-current assets
2,644
(901
)
Accounts payable
278
(328
)
Accrued liabilities
(610
)
(1,873
)
Accrued interest
118
92
Other current liabilities
(2
)
(4,967
)
Contract liabilities
(1,098
)
851
Lease liability
(859
)
(908
)
Other non-current liabilities
18
(23
)
Net cash used in operating activities
(45,987
)
(71,495
)
Cash flows from investing activities:
Purchases of property, machinery and equipment
(94
)
(618
)
Proceeds from sale of property, machinery and equipment
113
7
Purchases of intangible assets
(26
)
(30
)
Net cash used in investing activities
(7
)
(641
)
Cash flows from financing activities:
Proceeds from exercise of stock options
130
517
Proceeds from employee stock purchase plan
31
190
Repurchase of Section 16 Officer shares for tax coverage exchange
(87
)
(265
)
Principal payments on loan payable
(9,592
)
(6,686
)
Payment of deferred offering costs
(252
)
—
Payment for repurchase of common shares
(10,000
)
—
Proceeds from issuance of common stock and related warrants
15,000
—
Payments for issuance costs related to common stock and related warrants
(1,135
)
—
Net cash used in financing activities
(5,905
)
(6,244
)
Decrease in cash, cash equivalents and restricted cash
(51,899
)
(78,380
)
Cash, cash equivalents and restricted cash, beginning of period
62,413
160,547
Cash, cash equivalents and restricted cash, end of period
$
10,514
$
82,167
Supplemental disclosure of non-cash investing and financing activities
Purchases of intangible assets in accounts payable and accrued expenses at period end
$
5
$
—
Issuance costs related to warrant modification
$
648
$
—
Deferred offering costs in accounts payable and accrued expenses at period end
$
—
$
238
Stock repurchase liability fair value
$
—
$
10,000
Supplemental disclosure of cash flow information
Cash paid for interest
$
882
$
1,960
Use of Non-GAAP Financial Measures (unaudited)
This press release references certain non-GAAP financial measures, including adjusted EBITDA, non-GAAP selling, general, and administrative expense and non-GAAP research and development expense. The Company defines adjusted EBITDA as earnings before interest expense, taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. The Company defines non-GAAP selling, general, and administrative expenses and research and development expenses as those respective GAAP amounts, excluding stock-based compensation and non-recurring items not indicative of core operating performance None of these non-GAAP financial measures is a substitute for or superior to measures of financial performance prepared in accordance with generally accepted accounting principles in the United States (GAAP) and should not be considered as an alternative to any other performance measures derived in accordance with GAAP.
The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company that is helpful in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.
Quarterly adjusted EBITDA
A reconciliation of adjusted EBITDA to net loss for the three months ended September 30, 2023, September 30, 2022, and June 30, 2023, is set forth below:
Three Months Ended
(in thousands)
September 30, 2023
September 30, 2022
June 30, 2023
Net loss
$
(15,159
)
$
(21,298
)
$
(18,835
)
Interest income
(216
)
(28
)
(357
)
Interest expense
530
1,261
732
Depreciation & amortization
215
253
223
EBITDA
(14,630
)
(19,812
)
(18,237
)
Change in fair value of warrant liability
(221
)
(1,579
)
(451
)
Realized loss on disposal of assets
—
45
17
SEC and CFIUS legal expenses
86
279
177
Class action litigation legal expenses
132
621
24
Other non-recurring litigation legal expense
959
447
756
SEC compliance costs
631
20
327
NSA compliance costs
226
487
398
Severance and other non-recurring expenses1
69
90
—
Stock-based compensation
2,156
3,289
2,577
Adjusted EBITDA
$
(10,592
)
$
(16,113
)
$
(14,412
)
1 - Loss contingencies for certain severance agreements were reversed when the Company determined they would not be signed and paid
A reconciliation of selling, general, and administrative expenses to non-GAAP selling, general, and administrative expenses for the three months ended September 30, 2023, September 30, 2022, and June 30, 2023, is set forth below:
Three Months Ended
(in thousands)
September 30, 2023
September 30, 2022
June 30, 2023
Selling, general, and administrative expenses
$
9,294
$
11,184
$
10,007
Stock-based compensation
1,684
2,552
1,896
SEC and CFIUS legal expenses
86
279
177
Class action litigation legal expenses
132
621
24
Other non-recurring litigation legal expense
959
447
756
SEC compliance costs
631
20
327
NSA compliance costs
226
487
398
Non-GAAP selling, general, administration expenses
$
5,561
$
6,726
$
6,429
1 - Loss contingencies for certain severance agreements were reversed when the Company determined they would not be signed and paid
A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended September 30, 2023, September 30, 2022, and June 30, 2023, is set forth below:
Three Months Ended
(in thousands)
September 30, 2023
September 30, 2022
June 30, 2023
Research and development expenses
$
5,992
$
10,571
$
10,204
Stock-based compensation
472
737
681
Severance and non-recurring expenses1
53
38
—
Non-GAAP Research and development expenses
$
5,467
$
9,796
$
9,523
1 - Loss contingencies for certain severance agreements were reversed when the Company determined they would not be signed and paid
View source version on businesswire.com: https://www.businesswire.com/news/home/20231114211782/en/
For media inquiries: press@momentus.space
For investor relations inquiries: investors@momentus.space
1 Year Momentus Chart |
1 Month Momentus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions